HomePage | Biosensors International Ltd
Biosensors Launches Chroma at EuroPCR We have launched Chroma™, our innovative cobalt chromium bare-metal stent (BMS), at EuroPCR 2014.
Chroma received CE Mark approval in October 2013 and is now in the process of being launched in most major European markets and selected regions in the Middle East, Africa and Asia.
BioMatrix NEOFLEX™
BioMatrix NeoFlex™ is the latest addition to the BioMatrix family of drug-eluting stents (DES).™
It features an enhanced catheter delivery system with a lower entry profile than its predecessor, so improving pushability, trackability and crossability. BioMatrix NeoFlex retains the same unique combination of abluminal biodegradable polymer coating, Biolimus A9™ and flexible platform which have made the BioMatrix family of DES so popular.
Completion of Enrolment in LEADERS FREE: Patient Population Data Presented at EuroPCR. Following completion of enrolment, the baseline population data from the LEADERS FREE study was presented for the first time at EuroPCR. This study, involving BioFreedom, is the world's first prospective randomised double-blind study employing only a one-month course of DAPT after implantation of an active stent.
FY15 Q1
Results Webcast
Wednesday, 6 August 2014, 6pm Singapore time